DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Merck & Co., Inc.

NYSE: MRK

+ Add to Portfolio

company name or ticker
Company Photos
(Click to zoom)
Working at Merck & Co., Inc.

The 4 Best Large-Cap Companies for Workplace Diversity

These four companies make the diversity of their workforce a high priority -- an important consideration for any investor's company valuation.
5/11/2013 by DailyFinance

“Marketing Without Innovation”: a Merck Story

5/10/2013 by YCharts

Big Oil's Fall Holds Back a Flat Dow's Friday

Exxon and Chevron slump into the red as Merck rises.
5/10/2013 by DailyFinance

No Fat in This Drug Launch

Amarin releases sales for the first quarter that Vascepa was on the market.
5/10/2013 by DailyFinance

Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog

Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog
5/10/2013 by Zacks

Pharma’s Failure: Drug Spending Finally Declines

5/9/2013 by YCharts

Markets Couldn't Hold Early Gains: Dow Falls 22 Points

Despite strong earnings reports and a positive jobs report, the markets moved lower today.
5/9/2013 by DailyFinance

Merck & Co Inc (MRK): Today's Featured Drugs Winner

5/9/2013 by TheStreet

5 Stocks This Legendary Value Investor Is Backing

5/9/2013 by Seeking Alpha

GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’

5/9/2013 by DailyFinance
See More Articles...